The placenta provides essential nourishment and protection to a developing fetus, but new research has suggested that a common cold virus may be able to cross this barrier.
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
Published in Nature, new research elucidates the mechanism behind malarial resistance to piperaquine and suggests how this knowledge could be used to combat its spread.
A new study from Washington University School of Medicine in St. Louis reveals how the household environment can influence the transmission dynamics of methicillin-resistant Staphylococcus aureus.
Results from a new survey of young adults has suggested a poor knowledge of HIV transmission, persisting stigma around living with HIV and high-risk sexual behaviours.
A team of researchers presented the first large-scale evidence that releasing Wolbachia-infected mosquitoes reduced dengue infections by >70% in high-risk populations.
A study published today in the Journal of the America Medical Informatics Association has demonstrated that a new digital sepsis monitoring system implemented in three Imperial College Healthcare NHS Trust (London, UK) hospitals lowered the odds of death from sepsis by 24%.
The US FDA has approved cefiderocol (Fetroja), a siderophore cephalosporin that inhibits bacterial cell wall synthesis. Fetroja is the first approved antibiotic that functions as a siderophore.
The CDC has released an updated report outlining the burden of antimicrobial resistance in the USA and the greatest threats that face this country.